Physician profile
Joy Rodriguez
NPI 1508524380
$1,660.33
in general payments reported to CMS, 2019-2025
17 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $885 · 2023: $474 · 2024: $147 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $443.03 | 2022 | |
| Abbott Laboratories | $181.59 | 2023 | Assurity |
| Kestra Medical Technology Services, INC. | $175.91 | 2022-2024 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $164.20 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.04 | 2022-2024 | Jardiance |
| Novo Nordisk INC | $132.60 | 2024-2025 | Wegovy, Ozempic |
| Boston Scientific Corporation | $79.06 | 2022 | |
| Cvrx, INC. | $67.61 | 2022 | |
| Philips North America LLC | $66.53 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $35.86 | 2022-2024 | Amvuttra |
| Bridgebio Pharma, INC. | $33.66 | 2025 | Attruby |
| Pfizer INC. | $32.14 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $24.72 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.35 | 2023 | Xarelto |
| Altathera Pharmaceuticals LLC | $16.70 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $14.14 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.19 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.